Bromodomain containing 9 pseudogene 2 (BRD9P2)

Bromodomain containing 9 pseudogene 2 (BRD9P2) is a human gene classified as a pseudogene; it does not produce a functional protein and therefore is not considered a molecular target for drug action, biomarker evaluation, or disease association. BRD9P2 is distinct from the functional gene BRD9, which encodes a member of the bromodomain family involved in chromatin remodeling, transcription regulation, and is implicated in various cancers[3][4][6]. The "pseudogene" designation means BRD9P2 may share sequence similarity with BRD9 but lacks confirmed biological activity, molecular function, or disease relevance in therapeutics[1][5][7][9]. BRD9P2 is frequently confused with BRD9, a legitimate protein-coding gene and cancer therapeutic target[2][3][4]. BRD9P2's annotation as a pseudogene means it is neither a receptor, enzyme, nor any conventional therapeutic target type, and databases do not ascribe molecular activity or clinical relevance to it[9]. Therefore, BRD9P2 is not a currently actionable drug discovery target.

Other names

BRD9P2